Get started
Author

Antonio Luca Maria Parlati

Observed names: A Parlati, Antonio L. M. Parlati, Antonio L.M. Parlati, Antonio LM Parlati, Antonio Parlati
Observed institutions: King's College London, British Heart Foundation, Centro Cardiologico Monzino, Federico II University Hospital, IRCCS Ospedale San Raffaele, Ospedale Monaldi, National Research Council, Fondazione Toscana Gabriele Monasterio, University of Naples Federico II
ORCID: 0009-0005-2297-7845
Observed ORCID: 0009-0005-2297-7845
OpenAlex ID: A5024523034
Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice
2024 · Cristina Madaudo, Giuseppe Coppola, et al. · International Journal of Molecular Sciences · 82
PDF
Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry
2024 · Paola Gargiulo, Christian Basile, et al. · European Journal of Preventive Cardiology · 57
PDF
MicroRNAs: Diagnostic, Prognostic and Therapeutic Role in Heart Failure—a Review
2022 · Paola Gargiulo, Federica Marzano, et al. · ESC Heart Failure · 52
Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under‐diagnosed disease
2022 · Maria Prastaro, Ermanno Nardi, et al. · Journal of Clinical Ultrasound · 39
ANOCA, INOCA, MINOCA: The New Frontier of Coronary Syndromes
2025 · Antonio L. M. Parlati, Ermanno Nardi, et al. · Journal of Cardiovascular Development and Disease · 38
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice
2024 · Cristina Madaudo, Antonio Luca Maria Parlati, et al. · Journal of Cardiovascular Medicine · 30
Depression in Heart Failure with Reduced Ejection Fraction, an Undervalued Comorbidity: An Up-To-Date Review
2023 · Christian Basile, Antonio Luca Maria Parlati, et al. · Medicina · 29
PDF
Cardiovascular disease and psychiatric disorders: An-up-to date review
2024 · Antonio Luca Maria Parlati, Ermanno Nardi, et al. · Journal of Public Health Research · 23
Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies
2025 · Antonio Luca Maria Parlati, Ermanno Nardi, et al. · Journal of Clinical Medicine · 21
PDF
Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions
2025 · Antonio Luca Maria Parlati, Cristina Madaudo, et al. · Cardiac failure review · 20
PDF
Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation
2020 · Cosmo Godino, Francesca Bodega, et al. · Journal of Cardiovascular Medicine · 18
Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis
2022 · Christian Basile, Stefania Paolillo, et al. · Journal of Cardiovascular Medicine · 17
123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation
2022 · Paola Gargiulo, Wanda Acampa, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 17
PDF
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion
2022 · Antonio Sisinni, Andrea Munafò, et al. · The American Journal of Cardiology · 15
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation
2020 · Cosmo Godino, Antonio Sisinni, et al. · The American Journal of Cardiology · 14
Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes
2023 · Francesco Melillo, Giulio Leo, et al. · International Journal of Cardiology · 7
Management of heart failure: similarities and discrepancies between the European Society of Cardiology and the American Heart Association guidelines
2023 · Antonio Luca Maria Parlati, Christian Basile, et al. · European Heart Journal Supplements · 7
PDF
Crosslink between atrial fibrillation and cancer: a therapeutic conundrum
2024 · Ermanno Nardi, Ciro Santoro, et al. · Cardio-Oncology · 6
Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence
2026 · Antonio LM Parlati, Luca Martini, et al. · Clinical Medicine Insights Cardiology · 3
Multimodality Assessment for Durable Mechanical Circulatory Support Implantation
2025 · Luca Martini, Antonio Pagliaro, et al. · Diagnostics · 3
PDF
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs)
2023 · Giulia Nemola, Anita Russi, et al. · The American Journal of Cardiology · 3
Gastrointestinal Bleeding During Long-Term Left Ventricular Assist Device Support: External Validation of UTAH Bleeding Risk Score
2025 · Giuseppe Vadalà, Cristina Madaudo, et al. · Journal of Cardiovascular Development and Disease · 2
Impact of Insulin Resistance and Preclinical Atherosclerosis Parameters in Long-Term Prediction of Cardiovascular Events: A Seven-Year Prospective Study
2026 · Daniela Di Lisi, Girolamo Manno, et al. · Journal of Clinical Medicine · 1
PDF
Heatwaves in HF: From risk to clinical action
2026 · Antonio Luca Maria Parlati, Luca Martini, et al. · Heart Failure Reviews
Implementation of guideline-directed cardioprotective therapy in patients living with type 2 diabetes in outpatient cardiology ambulatory setting: the Italian CardioMET registry
2026 · Paola Gargiulo, Federica Marzano, et al. · European Journal of Internal Medicine
PDF
Works count: 30
Citation count: 504
H-index: 14
I10-index: 15
Year
Topic
Type